HilleVax, Inc HLVX IPO will take place April, 29 on the NASDAQ exchange under the ticker HLVX.
The company is offering shares at an expected price between $16.00 and $18.00 per share with an insider lock-up period of 180 days ending on October 26, 2022.
See also: Benzinga IPO Calendar
About HilleVax, Inc
HilleVax is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines.
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in